Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis
Author(s) -
Laurence Brunet,
Erica E. M. Moodie,
Kathleen Rollet,
Curtis Cooper,
Sharon Walmsley,
Martin Potter,
Marina B. Klein
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit378
Subject(s) - medicine , cirrhosis , coinfection , gastroenterology , liver disease , hepatitis c , hazard ratio , proportional hazards model , prospective cohort study , cohort , hepatitis c virus , cohort study , immunology , confidence interval , human immunodeficiency virus (hiv) , virus
Marijuana smoking is common and believed to relieve many symptoms, but daily use has been associated with liver fibrosis in cross-sectional studies. We aimed to estimate the effect of marijuana smoking on liver disease progression in a Canadian prospective multicenter cohort of human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfected persons.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom